Physician profile
Alexandre Arkader
NPI 1891993473
$33,138.41
in general payments reported to CMS, 2019-2025
8 companies · $2,272 in 2025
The $2,272 reported for 2025 was more than what 82% of Pediatric Orthopaedic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,860 · 2020: $2,685 · 2021: $5,143 · 2022: $6,242 · 2023: $2,312 · 2024: $7,625 · 2025: $2,272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $7,152 · Consulting Fee: $4,950 · Food and Beverage: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $7,152.31 |
| Consulting Fee | $4,949.82 |
| Food and Beverage | $106.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthopediatrics Corp. | $32,545.79 | 2019-2025 | |
| Orthofix Medical, INC. | $362.38 | 2019 | |
| Onkos Surgical, INC. | $62.01 | 2024 | Eleos Limb Salvage System |
| Depuy Synthes Sales INC. | $55.40 | 2022 | |
| Nuvasive Specialized Orthopedics, INC. | $42.58 | 2019 | |
| Wright Medical Technology, INC. | $25.76 | 2019 | |
| Stryker Corporation | $24.09 | 2023 | Claw II |
| Sanara Medtech INC. | $20.40 | 2023 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandre Arkader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.